Pharming Group NV operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharming Group with three other
miscellaneous service companies in Europe:
of the United Kingdom
sales of £12.03 million [US$15.02 million]
of which 67%
was Research and development),
argen X BV
(14.71 million Euro [US$15.89 million]
based in Norway
(114.48 million Norwegian Kroner [US$13.53 million]
During the year ended December of 2016, sales at
Pharming Group were 15.87 million Euro (US$17.14 million).
increase of 46.6%
versus 2015, when the company's sales were 10.83 million Euro.
Despite this increase, sales are still
below the level achieved in 2014, when Pharming Group
reported sales of 21.19 million Euro.